Swiss biotech Melodia sings $275M song for Alivexis’ preclinical cathepsin C inhibitor 0 21.06.2024 12:08 Fiercebiotech.com Swiss biotech Melodia sings $275M song for Alivexis’ preclinical cathepsin C inhibitor jwaldron Fri, 06/21/2024 - 05:08